Physician profile
Ivan L Ayala
NPI 1497830897
$7,299.92
in general payments reported to CMS, 2019-2025
15 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,485 · 2020: $51.79 · 2021: $1,060 · 2022: $2,505 · 2023: $830 · 2024: $1,236 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,197.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $3,018.74 | 2019-2024 | |
| Heartflow, INC. | $1,987.06 | 2020-2025 | Ffrct |
| Abbott Laboratories | $966.23 | 2019-2022 | |
| Edwards Lifesciences Corporation | $155.20 | 2019 | |
| Medtronic Vascular, INC. | $151.67 | 2019-2020 | |
| Medtronic, INC. | $136.09 | 2022 | |
| Abiomed | $132.73 | 2022 | |
| Silk Road Medical, INC. | $129.04 | 2022 | |
| Elutia, INC. | $126.17 | 2022 | |
| Siemens Medical Solutions USA, INC. | $123.91 | 2022 | |
| Boston Scientific Corporation | $118.12 | 2021 | |
| Cleerly, INC. | $102.49 | 2024 | Cleerly Ischemia, Cleerly Labs |
| Cvrx, INC. | $73.81 | 2022 | |
| Ge Healthcare | $55.75 | 2019-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.91 | 2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ivan Ayala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.